Crane Alan L
SEC-identified person · CIK 1294361 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Pandion Therapeutics, Inc. PAND | Director | filed 2020 - 2021 |
| Vaccinex, INC. VCNX | Director | filed 2019 - 2019 |
| Dare Bioscience, Inc. DARE | Director | filed 2014 - 2016 |
| T2 Biosystems, Inc. TTOO | Director | filed 2014 - 2014 |
| Ocular Therapeutix, INC OCUL | Director | filed 2014 - 2014 |
| Momenta Pharmaceuticals INC MNTA | Director · President, CEO | filed 2006 - 2010 |
| Sirtris Pharmaceuticals, Inc. SIRT | Director | filed 2007 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.